Verition Fund Management LLC Bausch Health Companies Inc. Call Options Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $32,277 - $42,029	-5,300 Reduced 10.13%	47,000 $295,000
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $67,784 - $136,308	14,800 Added 39.47%	52,300 $360,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $88,250 - $295,375	-12,500 Reduced 25.0%	37,500 $313,000
Q4 2021 May 03, 2022	SELL	$23.0 - $29.01 $188,600 - $237,882	-8,200 Reduced 14.09%	50,000 $1.38 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $1.6 Million - $1.9 Million	58,200 New	58,200 $1.71 Million

275

279M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.99B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.